[1]Melnikova, I. Rare diseases and orphan drugs. Nat Rev Drug Discov.2012;11, 267–268.
[2]Song P, Gao J, Inagaki Y, Kokudo N, Tang W. Rare diseases, orphan drugs,and their regulation in Asia: current status and future perspectives. Intractable Rare Dis Res. 2012;1(1):3–9.
[3]Ma D, Li DG, Zhang X, He L. Opportunities and challenges in the prevention and treatment of rare diseases in China (in Chinese). Chinese Journal of Evidence-based Pediatrics. 2011; 6:81-82.
[4]Abbott, A. Rare-disease project has global ambitions. Nature. 2011; 472(7341):17.
[5] Yaneva–Deliverska M. Rare diseases and genetic discrimination[J]. Journal of IMAB–Annual Proceeding Scientific Papers. 2011;17(1): 116-119.
[6]He JJ, Song P, Kang Q, Zhang X, Hu JH, Yang Y, et al. Overview on social security system of rare diseases in China[J]. Bioscience trends, 2019; 13(4):314-323.
[7] Schieppati A, Henter J I, Daina E, Aperia A. Why rare diseases are an important medical and social issue[J]. The Lancet, 2008;371(9629): 2039-2041.
[8] Sood S, Lim R, Collins L, Trajanovska M, Hutson JM, Teague WJ, et al. The long-term quality of life outcomes in adolescents with Hirschsprung disease. Journal of pediatric surgery.2018; 53(12): 2430-2434.
[9] Rajmil L, Perestelo-Pérez L, Herdman M. Quality of life and rare diseases. Advances in experimental medicine and biology.2010;686: 251-272.
[10] Varni J W, Burwinkle T M, Seid M, Skarr D. The PedsQL™* 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambulatory pediatrics.2003;3(6): 329-341.
[11] Sheldrick R C, Neger E N, Shipman D, Perrin EC. Quality of life of adolescents with autism spectrum disorders: Concordance among adolescents’ self-reports, parents’ reports, and parents’ proxy reports. Quality of Life Research.2012; 21(1): 53-57.
[12]Eiser C, Morse R. Can parents rate their child's health-related quality of life? Results of a systematic review. Quality of life research.2001;10(4): 347-357.
[13]Rudolph T, Larsen J P, Farbu E. The long‐term functional status in patients with Guillain‐Barré syndrome. European journal of neurology. 2008; 15(12): 1332-1337.
[14] Aslan BI, Gülsen A, Tirank SB, Findikçioglu K, Uzuner FD, Tutar H, et al. Family functions and life quality of parents of children with cleft lip and palate. Journal of Craniofacial Surgery. 2018;29(6): 1614-1618.
[15]Tran VQ, Mahler T, Dassonville M, Truong DQ, Robert A, Goyens P, et al. Long-term outcomes and quality of life in patients after soave pull-through operation for Hirschsprung's disease: an observational retrospective study. European journal of pediatric surgery. 2018; 28(05): 445-454.
[16] Storch E, Keeley M, Merlo L, Jacob M, Correia C, & Weinstein D. Psychosocial functioning in youth with glycogen storage disease type I. Journal of Pediatric Psychology.2008; 33(7): 728-738.
[17]Sluys K P, Lannge M, Iselius L, Eriksson LE. Six years beyond pediatric trauma: child and parental ratings of children’s health-related quality of life in relation to parental mental health. Quality of Life Research.2015;24(11): 2689-2699.
[18]Varmi JW, Seid M, Kurtin P. PedsQLTM 4.0: Reliability and validity of the Pediatric Quality of Life InventoryTM Version 4.0 Generic Core Scales in healthy and patient populations. Medical Care.2001; 39: 800-812.
[19]Reinfjell T, Diseth T H, Veenstra M, Vikan A. Measuring health-related quality of life in young adolescents: Reliability and validity in the Norwegian version of the Pediatric Quality of Life Inventory™ 4.0 (PedsQL) generic core scales. Health and quality of life outcomes. 2006;4(1): 61.
[20]Varni JW, Limbers C A, Burwinkle T M. Parent proxy-report of their children's health-related quality of life: an analysis of 13,878 parents' reliability and validity across age subgroups using the PedsQL™ 4.0 Generic Core Scales. Health and quality of life outcomes.2007; 5(1): 2.
[21] Huang Y, Zhong XN, Li QY, Xu D, Zhang X L, Feng C, et al. Health-related quality of life of the rural-China left-behind children or adolescents and influential factors: a cross-sectional study. Health and quality of life outcomes. 2015;13(1): 29.
[22]Wu H, Li H, Gao Q. Psychometric properties of the Chinese version of the pediatric quality of life inventory 4.0 Generic core scales among children with short stature. Health and quality of life outcomes.2013;11(1): 87.
[23]Sluys K P, Lannge M, Iselius L, Eriksson LE. Six years beyond pediatric trauma: child and parental ratings of children’s health-related quality of life in relation to parental mental health. Quality of Life Research. 2015;24(11): 2689-2699.
[24]Vieira Neto E, Maia Filho HS, Monteiro CB, Carvalho LM, Tonon T, Vanz AP, et al. Quality of life and adherence to treatment in early-treated Brazilian phenylketonuria pediatric patients. Brazilian Journal of Medical and Biological Research.2018;51(2).
[25]Ji Y, Chen S, Li K, Xiao N, Yang X, Zheng S, et al. Measuring health-related quality of life in children with cancer living in Mainland China: feasibility, reliability and validity of the Chinese Mandarin version of PedsQL 4.0 Generic Core Scales and 3.0 Cancer Module. Health and quality of life outcomes.2011; 9(1): 103.
[26] Sundaram SS, Alonso EM, Haber B, Magee JC, Fredericks E, Kamath B, et al. Health related quality of life in patients with biliary atresia surviving with their native liver. The Journal of pediatrics. 2013; 163(4): 1052-1057.
[27] Zhang H, Wang L, Quan M, Huang J, Wu P, Lu Q, et al. Health-related quality of life in children with chronic immune thrombocytopenia in China. Health and quality of life outcomes. 2016; 14(1): 45.
[28] Neunert CE, Buchanan GR, Blanchette V, Barnard D, Young NL, Curtis C, et al. Relationships among bleeding severity, health‐related quality of life, and platelet count in children with immune thrombocytopenic purpura. Pediatric blood & cancer.2009; 53(4): 652-654.
[29]Michel M. Immune thrombocytopenic purpura: epidemiology and implications for patients. European Journal of Haematology. 2009;82: 3-7.
[30] Sood S, Lim R, Collins L, Trajanovska M, Hutson JM, Teague WJ, et al. The long-term quality of life outcomes in adolescents with Hirschsprung disease. Journal of pediatric surgery. 2018;53(12): 2430-2434.
[31] Collins L, Collis B, Trajanovska M, Khanal R, Hutson JM, Teague W, et al. Quality of life outcomes in children with Hirschsprung disease. Journal of pediatric surgery.2017;52(12): 2006-2010.
[32] Kwon EN, Mussatto K, Simpson PM, Brosig C, Nugent M, Samyn MM. Children and adolescents with repaired tetralogy of fallot report quality of life similar to healthy peers. Congenital heart disease. 2011;6(1): 18-27.
[33]Mills J L A, Konkin D E, Milner R, Penner JG, Langer M, Webber EM. Long-term bowel function and quality of life in children with Hirschsprung's disease. Journal of pediatric surgery. 2008; 43(5): 899-905.
[34] Damiano PC, Tyler MC, Romitti PA, Momany ET, Jones MP, Canady JW.,et al. Health-related quality of life among preadolescent children with oral clefts: the mother's perspective. Pediatrics. 2007; 120(2): e283-e290.
[35] Ma Z, Zheng XY. Analysis of the health service utilization among patients with rare diseases and the influencing factors in China (in Chinese). Chinese Journal of Health Policy.2018; 11(11):60-64.
[36] Shao WB, Li YY, Wang F, Zhu YJ, Xiao L,Huang RF. The current situation and suggestions on the orphan drugs availability in China (in Chinese).. Food & Drug Administration Magazine. 2019; 181(02):10-17.
[37] Wang P, Zhang YF. On the Coping Strategies of Rare Diseases in Britain
and Its Enlightenment to China (in Chinese). Medicine & Jurisprudence.2016; 8(2):70-75.